August 16, 2026 01:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar | Bengal man arrested in Bengaluru over terror links, Afghanistan travel plan | Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe
COVID19 Vaccine
Image credit: Janssen/UN website

Key workers in 145 countries to receive COVID vaccines under UN-backed initiative

| @indiablooms | Feb 05, 2021, at 02:04 am

New York: Key workers and other vulnerable people in 145 countries should receive COVID-19 vaccines in the first half of this year, under the joint UN-led COVAX initiative for fair access to coronavirus-beating jabs, it’s been confirmed.

The aim of Wednesday’s announcement by the World Health Organization (WHO) and partners, is to help Governments to prepare their vaccine distribution programmes, by providing details about which vaccine they can expect to receive, between now and the end of June.

UN Children’s Fund UNICEF – which plays a key role in immunisation campaigns worldwide - welcomed the development, describing COVAX as the largest vaccine procurement and supply operation ever mounted.

Get it right

“We must get this right”, said Executive Director Henrietta Fore. “Our country offices will support governments as they move forward with this first wave to ensure that they are ready to receive the vaccines that require ultra-cold chain (storage).

“This includes ensuring that health workers are fully trained in how to store and handle the vaccines…Many of these doses will go to health workers in urban areas who are at the highest risk of exposure to COVID-19 infections.”

Some 1.2 million doses of the Pfizer-BioNTech vaccine which requires ultra-cold chain storage, are to be delivered to 18 countries in the first quarter of the year, out of an agreed total of 40 million.

An additional 336 million doses of the AstraZeneca/Oxford jab are to be lined up for dispatch to nearly all countries that have signed up to the COVAX scheme, from Afghanistan to Zimbabwe – once it has been approved for use by the UN health agency.

The total number of doses will cover, on average, 3.3 per cent of the population of the countries benefiting from the scheme.

This will make it possible for governments to protect their most vulnerable citizens - such as front-line health care workers, the World Health Organization said, along with Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations.

‘Ultra-cold’ project

Ahead of Wednesday’s announcement, UNICEF chief Ms Fore noted that the agency had been getting ready by stockpiling half a billion syringes and working with airlines, governments and other partners to iron out potential supply hiccups.

“This work has already begun”, she said. “For example, Bosnia and Herzegovina is one of the countries that will be an early recipient of the Pfizer vaccine, which requires ultra-cold chain storage. UNICEF is providing Bosnia and Herzegovina with eight refrigerators that will be able to store vaccines in temperatures as low as -80 degrees Celsius. The first two refrigerators recently arrived…The rest will follow as soon as possible.”

In a related development on Wednesday, Ms. Fore also announced the signing of a deal securing 1.1 billion doses of COVID-19 vaccines for around 100 countries.

The agreement with the Serum Institute of India is for the AstraZeneca/Oxford vaccine and the Novavax vaccine, both of which have yet to receive Emergency Use Listing by the WHO.

Low and middle income countries will pay approximately $3 per dose, Ms. Fore said. “This is great value for COVAX donors and a strong demonstration of one of the fundamental principles of COVAX – that by pooling our resources we can negotiate in bulk for the best possible deals.”

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.